Outpatient Treatments for COVID-19 Reviewed- Interview with Dr. Pierre Kory and Dr. Mercola

Dr. Pierre Kory is one of the leaders in the movement to provide early treatment for COVID infection. Kory is a critical care physician (ICU specialist), triple board certified in internal medicine, critical care and pulmonary medicine, and is part of the Frontline COVID-19 Critical Care Alliance (FLCCC), which was among the first to publish COVID treatment guidance.

• From the start of the COVID pandemic, doctors were told they could not use any treatment that had not undergone randomized controlled trials. Most all clinical successes have been ignored and vehemently opposed
• The Frontline COVID-19 Critical Care Alliance (FLCCC) was among the first to publish COVID treatment guidance. They have since developed protocols for prevention, early at-home treatment, in-hospital treatment and maintenance guidance for long-haul COVID syndrome that are updated as more becomes known
• Corticosteroids can be an effective tool for reducing inflammation in general, but they appear particularly important for advanced COVID infection. Steroids should not be used early on, but can be lifesaving after you develop signs of lung dysfunction and increased oxygen requirement
• Ivermectin has antiviral and anti-inflammatory properties and is beneficial in all stages of COVID-19, from prevention to advanced illness
• Other effective protocols include the AAPS protocol, Tess Laurie’s World Council for Health protocol and the America’s Frontline Doctors’ protocol